Literature DB >> 20181917

Prevalence and characteristics of the O122 pathogenicity island in typical and atypical enteropathogenic Escherichia coli strains.

Mônica A M Vieira1, Fábia A Salvador, Rosa M Silva, Kinue Irino, Tânia M I Vaz, Anna C Rockstroh, Beatriz E C Guth, Tânia A T Gomes.   

Abstract

The presence of the pathogenicity island (PAI) O122 genes, efa1 (lifA), sen, pagC, nleB, and nleE, in typical and atypical enteropathogenic Escherichia coli (EPEC) strains was investigated. The simultaneous occurrence of all genes was statistically associated with diarrhea due to atypical EPEC. Detection of the complete PAI O122 could aid in the identification of potential pathogenic strains of atypical EPEC.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20181917      PMCID： PMC2849565          DOI： 10.1128/JCM.01944-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells.

Authors:  L Nicholls; T H Grant; R M Robins-Browne
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

2.  Phenotypic and genotypic characteristics of Escherichia coli strains of non-enteropathogenic E. coli (EPEC) serogroups that carry EAE and lack the EPEC adherence factor and Shiga toxin DNA probe sequences.

Authors:  M A Vieira; J R Andrade; L R Trabulsi; A C Rosa; A M Dias; S R Ramos; G Frankel; T A Gomes
Journal:  J Infect Dis       Date:  2001-02-08       Impact factor: 5.226

3.  Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells.

Authors:  Luminita Badea; Stephen Doughty; Larissa Nicholls; Joan Sloan; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Microb Pathog       Date:  2003-05       Impact factor: 3.738

4.  The type III secretion effector NleE inhibits NF-kappaB activation.

Authors:  Chen Nadler; Kobi Baruch; Simi Kobi; Erez Mills; Gili Haviv; Marganit Farago; Irit Alkalay; Sina Bartfeld; Thomas F Meyer; Yinon Ben-Neriah; Ilan Rosenshine
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

5.  A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli.

Authors:  Stefano Morabito; Rosangela Tozzoli; Eric Oswald; Alfredo Caprioli
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Songhai Shen; Kim Ziebell; Shelley Johnson; Richard Reid-Smith; Judith Isaac-Renton; Clifford Clark; Kris Rahn; James B Kaper
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 7.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

8.  Escherichia coli and community-acquired gastroenteritis, Melbourne, Australia.

Authors:  Roy M Robins-Browne; Anne-Marie Bordun; Marija Tauschek; Vicki R Bennett-Wood; Jacinta Russell; Frances Oppedisano; Nicole A Lister; Karl A Bettelheim; Christopher K Fairley; Martha I Sinclair; Margaret E Hellard
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

Review 9.  Typical and atypical enteropathogenic Escherichia coli.

Authors:  Luiz R Trabulsi; Rogéria Keller; Tânia A Tardelli Gomes
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

10.  Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep.

Authors:  Mark P Stevens; Andrew J Roe; Isabella Vlisidou; Pauline M van Diemen; Roberto M La Ragione; Angus Best; Martin J Woodward; David L Gally; Timothy S Wallis
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441
View more
  16 in total

1.  Identification and characterization of atypical enteropathogenic and Shiga toxin-producing Escherichia coli isolated from ground beef and poultry breast purchased in Botucatu, Brazil.

Authors:  Rodrigo H S Tanabe; Melissa A Vieira; Noelle A B Mariano; Regiane C B Dias; Rafael Ventin da Silva; Caroline M Castro; Luis F Dos Santos; Carlos H Camargo; Ricardo S Yamatogi; Vera L M Rall; Rodrigo T Hernandes
Journal:  Braz J Microbiol       Date:  2019-06-11       Impact factor: 2.476

2.  Pathogenicity Island O-122 in enteropathogenic Escherichia coli strains is associated with diarrhea severity in children from Lima Peru.

Authors:  Erik H Mercado; Cristian Piscoche; Carmen Contreras; David Durand; Maribel Riveros; Joaquim Ruiz; Theresa J Ochoa
Journal:  Int J Med Microbiol       Date:  2016-05-10       Impact factor: 3.473

3.  Adhesin-encoding genes from shiga toxin-producing Escherichia coli are more prevalent in atypical than in typical enteropathogenic E. coli.

Authors:  Tânia A T Gomes; Rodrigo T Hernandes; Alfredo G Torres; Fábia A Salvador; Beatriz E C Guth; Tânia M I Vaz; Kinue Irino; Rosa M Silva; Mônica A M Vieira
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

4.  Comparative Genomics of Atypical Enteropathogenic Escherichia coli from Kittens and Children Identifies Bacterial Factors Associated with Virulence in Kittens.

Authors:  Victoria E Watson; Tracy H Hazen; David A Rasko; Megan E Jacob; Johanna R Elfenbein; Stephen H Stauffer; Jody L Gookin
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

5.  Norwegian sheep are an important reservoir for human-pathogenic Escherichia coli O26:H11.

Authors:  Lin T Brandal; Camilla Sekse; Bjørn-Arne Lindstedt; Marianne Sunde; Inger Løbersli; Anne Margrete Urdahl; Georg Kapperud
Journal:  Appl Environ Microbiol       Date:  2012-04-06       Impact factor: 4.792

6.  Virulence-Related Genes and Coenteropathogens Associated with Clinical Outcomes of Enteropathogenic Escherichia coli Infections in Children from the Brazilian Semiarid Region: a Case-Control Study of Diarrhea.

Authors:  Ana Karolina S Santos; Pedro Henrique Q S de Medeiros; Mariana D Bona; Mara M G Prata; Marília S M G Amaral; Herlice N Veras; Rafaela C Pankov; Samilly A Ribeiro; Paloma A Cavalcante; Thiago M Freitas; Rafhaella D G Gondim; Daniel M N de Oliveira; Natália K F M Melo; Alexandre Havt; Aldo A M Lima
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 7.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.

Authors:  Adilene Olvera; Hannah Carter; Anubama Rajan; Lily G Carlin; Xiaomin Yu; Xi-Lei Zeng; Samuel Shelburne; Micah Bhatti; Sarah E Blutt; Noah F Shroyer; Robert Jenq; Mary K Estes; Anthony Maresso; Pablo C Okhuysen
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

9.  Molecular and phenotypic characterization of Escherichia coli O26:H8 among diarrheagenic E. coli O26 strains isolated in Brazil.

Authors:  Roxane M F Piazza; Sabine Delannoy; Patrick Fach; Halha O Saridakis; Margareth Z Pedroso; Letícia B Rocha; Tânia A T Gomes; Mônica A M Vieira; Lothar Beutin; Beatriz E C Guth
Journal:  Appl Environ Microbiol       Date:  2013-08-23       Impact factor: 4.792

10.  Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains.

Authors:  Marie Bugarel; Annett Martin; Patrick Fach; Lothar Beutin
Journal:  BMC Microbiol       Date:  2011-06-21       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.